Insiders · Profile

Shepard H. Michael

VP, Chief Scientific Officer at HALOZYME THERAPEUTICS. Filing since 19 Aug 2013. CIK 0001507433

Company
Date
Role
Action
Shares
Amount
Of holding
19 Aug 2013
VP, Chief Scientific Officer
Sold, plan not stated
10,000
$71.09K
43.1%
1 decision on file.